What is the future of CCR5 antagonists in rheumatoid arthritis?
about
Chemokine receptor modeling: an interdisciplinary approach to drug design.The multiple chemokine-binding bovine herpesvirus 1 glycoprotein G (BHV1gG) inhibits polymorphonuclear cell but not monocyte migration into inflammatory sites.The HIV co-receptor CCR5 regulates osteoclast function.CCR5delta32 in systemic lupus erythematosus: implications for disease susceptibility and outcome in a Brazilian population.
P2860
What is the future of CCR5 antagonists in rheumatoid arthritis?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
What is the future of CCR5 antagonists in rheumatoid arthritis?
@en
What is the future of CCR5 antagonists in rheumatoid arthritis?
@nl
type
label
What is the future of CCR5 antagonists in rheumatoid arthritis?
@en
What is the future of CCR5 antagonists in rheumatoid arthritis?
@nl
prefLabel
What is the future of CCR5 antagonists in rheumatoid arthritis?
@en
What is the future of CCR5 antagonists in rheumatoid arthritis?
@nl
P2860
P356
P1476
What is the future of CCR5 antagonists in rheumatoid arthritis?
@en
P2093
Hideto Kameda
P2860
P2888
P356
10.1186/AR3775
P577
2012-03-30T00:00:00Z